Product information and disease descriptionPlace of product in therapyDisease description
Diagnosis
9 evidence topics · 11 sources
DSM-5 diagnostic criteria for generalized anxiety disorder
Clinical diagnosis without a biomarker
“Because no blood, genetic, or imaging biomarkers exist, diagnosis rests on mental-state history and examinations, which should therefore be sufficiently monitored by every primary care practitioner.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Categorical diagnostic criteria are clinically useful, but boundaries between anxiety disorders and normative anxiety are often ill-defined. Recognition of distinctions requires clinical judgement of severity, duration, persistence, and, importantly, degree of distress and impairment.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Structured interviews and rating scales
“Validated, structured, or semi-structured clinical interviews, such as the DSM-5-based or ICD-11-based composite international diagnostic interview9 or structured clinical interview for DSM disorders,10 can assist in correct diagnostics.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“To determine the severity of anxiety disorders and monitor treatment, continuous clinician-rated scales include, for example, the Hamilton Anxiety Scale.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Standardised diagnostics and assessments for outcome monitoring are part of evidence-based care, could prevent underdiagnosis, and lead to effective treatments. However, these diagnostics and assessments are still not widely used in clinical practice.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Identification and assessment: NICE clinical guideline CG113
Exclusion of medical causes and differential diagnosis
“For any patient presenting with increased pathological anxiety, a thorough psychiatric and somatic evaluation should consider whether symptoms reflect other health conditions or effects of substance or medication use.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Laboratory assessment of plasma thyroid-stimulating hormone” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Screening of adults: USPSTF recommendation, June 2023
Screening of adults: AFP review statement, August 2022, before the USPSTF recommendation of June 2023
Accuracy of the GAD-7 and GAD-2 screening instruments
“A criterion-standard study was performed in 15 primary care clinics in the United States from November 2004 through June 2005.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“A cut point was identified that optimized sensitivity (89%) and specificity (82%).” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“A total of 12 samples were identified involving 5223 participants; 11 samples provided data on the accuracy of the GAD-7 for identifying generalized anxiety disorder (GAD).” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“Pooled sensitivity and specificity values appeared acceptable at a cutoff point of 8 [sensitivity: 0.83 (95% CI 0.71-0.91), specificity: 0.84 (95% CI 0.70-0.92)] although cutoff scores 7-10 also had similar pooled estimates of sensitivity/specificity.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“Pooled sensitivity and specificity values appeared acceptable at a cutoff of 3 [sensitivity: 0.76 (95% CI 0.55-0.89), specificity: 0.81 (95% CI 0.60-0.92)].” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
Detection and treatment gaps in primary care
“Of the 965 patients, 19.5% (95% CI, 17.0% to 22.1%) had at least 1 anxiety disorder, 8.6% (CI, 6.9% to 10.6%) had posttraumatic stress disorder, 7.6% (CI, 5.9% to 9.4%) had a generalized anxiety disorder” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“Many patients (41%) with an anxiety disorder reported no current treatment.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“Receiver-operating characteristic curve analysis showed that both the GAD-7 scale and its 2 core items (GAD-2) performed well (area under the curve, 0.80 to 0.91) as screening tools for all 4 anxiety disorders.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote